JAN: JanOne Inc. Stock

by  •  • Comments Off on JAN: JanOne Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 38.80
Enterprise Value ($M) 54.01
Book Value ($M) 11.20
Book Value / Share 1.30
Price / Book 3.46
NCAV ($M) -6.94
NCAV / Share -0.81
Price / NCAV -5.59

Profitability (mra)
Return on Invested Capital (ROIC) -0.66
Return on Assets (ROA) -0.22
Return on Equity (ROE) -0.28

Liquidity (mrq)
Quick Ratio 0.06
Current Ratio 0.06

Balance Sheet (mrq) ($M)
Current Assets 0.35
Assets 18.49
Liabilities 7.29
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -4.75
Net Income -7.81
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 1.46
Cash from Investing -0.15
Cash from Financing -1.44

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
08-24 13G/A Bigger Capital Fund L P 3.90 -59.50

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-08 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-22 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-04-25 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1
2023-04-25 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-23 118,293 501,754 23.58
2024-04-22 80,673 298,722 27.01
2024-04-19 65,508 40,360 162.31
2024-04-18 17,524 37,629 46.57

(click for more detail)

Similar Companies
INTS – Intensity Therapeutics, Inc. ITRM – Iterum Therapeutics plc
JAGX – Jaguar Health, Inc. JSPR – Jasper Therapeutics, Inc.
KA – Kineta, Inc.


Financial data and stock pages provided by
Fintel.io